Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Morris

Showing results (321-330 of 350) with videos related to

Pageof 35
Sort By:
Pediatric Blood & Cancer|February 10, 2021
Second tumor risk in children treated with proton therapyDaniel J Indelicato, James E Bates, Raymond B Mailhot Vega, et al.
International Journal of Particle Therapy|May 17, 2024
Long-Term Outcomes Following Definitive or Adjuvant Proton Radiotherapy for Adenoid Cystic CarcinomaEtzer Augustin, Adam L Holtzman, Roi Dagan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Patient-Reported Sexual Survivorship Following High-Dose Image-Guided Proton Therapy for Prostate CancerAdam L Holtzman, Curtis M Bryant, Nancy P Mendenhall, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2016
Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused UltrasoundAdam L Holtzman, Bradford S Hoppe, Haley P Letter, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2013
Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppressionWhoon Jong Kil, Romaine C Nichols, Bradford S Hoppe, et al.
American Journal of Clinical Oncology|May 5, 2018
Rectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker PlacementWilliam M Mendenhall, Gail Sarto, Curtis M Bryant, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2014
Rectal toxicity after proton therapy for prostate cancer: an analysis of outcomes of prospective studies conducted at the university of Florida Proton Therapy InstituteRovel J Colaco, Bradford S Hoppe, Stella Flampouri, et al.
Acta Oncologica (Stockholm, Sweden)|December 15, 2017
Outcomes following proton therapy for pediatric ependymomaDaniel J Indelicato, Julie A Bradley, Ronny L Rotondo, et al.
International Journal of Radiation Oncology, Biology, Physics|March 20, 2022
Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 TrialBradford S Hoppe, Romaine C Nichols, Stella Flampouri, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate CancerCurtis Bryant, Tamara L Smith, Randal H Henderson, et al.
Pageof 35

Showing results (321-330 of 350) with videos related to

Sort By:
Pageof 35
Pediatric Blood & Cancer|February 10, 2021
Second tumor risk in children treated with proton therapyDaniel J Indelicato, James E Bates, Raymond B Mailhot Vega, et al.
International Journal of Particle Therapy|May 17, 2024
Long-Term Outcomes Following Definitive or Adjuvant Proton Radiotherapy for Adenoid Cystic CarcinomaEtzer Augustin, Adam L Holtzman, Roi Dagan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Patient-Reported Sexual Survivorship Following High-Dose Image-Guided Proton Therapy for Prostate CancerAdam L Holtzman, Curtis M Bryant, Nancy P Mendenhall, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2016
Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused UltrasoundAdam L Holtzman, Bradford S Hoppe, Haley P Letter, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2013
Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppressionWhoon Jong Kil, Romaine C Nichols, Bradford S Hoppe, et al.
American Journal of Clinical Oncology|May 5, 2018
Rectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker PlacementWilliam M Mendenhall, Gail Sarto, Curtis M Bryant, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2014
Rectal toxicity after proton therapy for prostate cancer: an analysis of outcomes of prospective studies conducted at the university of Florida Proton Therapy InstituteRovel J Colaco, Bradford S Hoppe, Stella Flampouri, et al.
Acta Oncologica (Stockholm, Sweden)|December 15, 2017
Outcomes following proton therapy for pediatric ependymomaDaniel J Indelicato, Julie A Bradley, Ronny L Rotondo, et al.
International Journal of Radiation Oncology, Biology, Physics|March 20, 2022
Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 TrialBradford S Hoppe, Romaine C Nichols, Stella Flampouri, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate CancerCurtis Bryant, Tamara L Smith, Randal H Henderson, et al.
Pageof 35